Advertisement
Home »

Survival outcomes for patients with relapsed/refractory aggressive B cell lymphomas following receipt of high dose chemotherapy/autologous stem transplantation and/or chimeric antigen receptor-modified T cells.

May 22, 2023

ABOUT THE CONTRIBUTORS

  • Daniel J Landsburg

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA. Electronic address: daniel.landsburg@pennmedicine.upenn.edu.

    Sunita D Nasta

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Jakub Svoboda

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    James N Gerson

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Stephen J Schuster

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Stefan K Barta

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Elise A Chong

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Heather Difilippo

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Elizabeth Weber

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Kathleen Cunningham

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Christopher Catania

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Alfred L Garfall

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Edward A Stadtmauer

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    Noelle V Frey

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

    David L Porter

    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement